Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Lexeo Therapeutics shares are trading higher after the company announced it was granted FDA Fast Track designation for LX2006, an AAVrh.10hFXN-based gene therapy candidate for the treatment of Friedreich's ataxia cardiomyopathy.

Author: Benzinga Newsdesk | April 16, 2024 07:37am

Posted In: LXEO